Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 14.13% is in line with its 5-year average of 15.09%, near the low end of its 5-year range (11.88%–37.94%).
As of the fiscal period ended Tuesday, June 30, 2026. 3.35% above its 12-month average of 13.67%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 14.13%.
RETURN ON EQUITY (ROE)
14.13%
RETURN ON EQUITY (ROE) AVG TTM
13.67%
RETURN ON EQUITY (ROE) AVG 3Y
13.11%
RETURN ON EQUITY (ROE) AVG 5Y
15.09%
RETURN ON EQUITY (ROE) AVG 10Y
14.25%
RETURN ON EQUITY (ROE) AVG 15Y
15.20%
RETURN ON EQUITY (ROE) AVG 20Y
15.55%
CURRENT VS TTM AVG
+3.35%
CURRENT VS 3Y AVG
+7.77%
CURRENT VS 5Y AVG
-6.38%
CURRENT VS 10Y AVG
-0.84%
CURRENT VS 15Y AVG
-7.01%
CURRENT VS 20Y AVG
-9.16%
SECTOR MEDIAN · HEALTHCARE
13.01%
median of 84 covered companies
CURRENT VS SECTOR MEDIAN
+8.61%
vs the sector median at left
Quest Diagnostics Incorporated
Market Cap
$26.11B
Return on Equity (ROE)
14.13%
TTM Avg
13.67%
3Y Avg
13.11%
5Y Avg
15.09%
Market Cap
$26.34B
Return on Equity (ROE)
18.89%
TTM Avg
16.95%
3Y Avg
19.08%
5Y Avg
20.56%
Market Cap
$25.18B
Return on Equity (ROE)
25.41%
TTM Avg
12.92%
3Y Avg
11.29%
5Y Avg
9.83%
Market Cap
$25.15B
Return on Equity (ROE)
11.65%
TTM Avg
9.71%
3Y Avg
9.35%
5Y Avg
12.84%
Market Cap
$25.06B
Return on Equity (ROE)
-9.62%
TTM Avg
-4.55%
3Y Avg
10.63%
5Y Avg
21.70%
Market Cap
$29.38B
Return on Equity (ROE)
5.97%
TTM Avg
9.02%
3Y Avg
4.86%
5Y Avg
4.86%
Market Cap
$29.38B
Return on Equity (ROE)
83.10%
TTM Avg
66.19%
3Y Avg
56.82%
5Y Avg
52.60%
Market Cap
$29.70B
Return on Equity (ROE)
14.51%
TTM Avg
21.84%
3Y Avg
21.53%
5Y Avg
32.27%
Market Cap
$30.68B
Return on Equity (ROE)
-22.60%
TTM Avg
-10.46%
3Y Avg
-1.37%
5Y Avg
1.10%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Quest Diagnostics Incorporated (DGX) | $26.11B | 14.13% | 13.67% | 13.11% | 15.09% |
| West Pharmaceutical Services, Inc. (WST)vs › | $26.34B | 18.89% | 16.95% | 19.08% | 20.56% |
| Incyte Corporation (INCY)vs › | $25.18B | 25.41% | 12.92% | 11.29% | 9.83% |
| Labcorp Holdings Inc. (LH)vs › | $25.15B | 11.65% | 9.71% | 9.35% | 12.84% |
| BioNTech SE (BNTX)vs › | $25.06B | -9.62% | -4.55% | 10.63% | 21.70% |
| Medline Inc. (MDLN)vs › | $29.38B | 5.97% | 9.02% | 4.86% | 4.86% |
| Zoetis Inc. (ZTS)vs › | $29.38B | 83.10% | 66.19% | 56.82% | 52.60% |
| GE HealthCare Technologies Inc. (GEHC)vs › | $29.70B | 14.51% | 21.84% | 21.53% | 32.27% |
| Centene Corp. (CNC)vs › | $30.68B | -22.60% | -10.46% | -1.37% | 1.10% |
| Mettler-Toledo International Inc. (MTD)vs › | $30.91B | 7062.40% | -2178.82% | -341.14% | -117.12% |
ROE
14.1%
ROA
6.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 14.13% |
| 2026-03-31 | 13.90% |
| 2025-12-31 | 13.84% |
| 2025-09-30 | 13.35% |
| 2025-06-30 | 13.14% |
| 2025-03-31 | 12.95% |
| 2024-12-31 | 12.85% |
| 2024-09-30 | 12.35% |
| 2024-06-30 | 12.69% |
| 2024-03-31 | 13.15% |
| 2023-12-31 | 13.54% |
| 2023-09-30 | 11.88% |
| 2023-06-30 | 12.67% |
| 2023-03-31 | 13.06% |
| 2022-12-31 | 15.99% |
| 2022-09-30 | 19.73% |
| 2022-06-30 | 23.07% |
| 2022-03-31 | 29.39% |
| 2021-12-31 | 30.85% |
| 2021-09-30 | 34.03% |
| 2021-06-30 | 37.94% |
| 2021-03-31 | 26.60% |
| 2020-12-31 | 21.08% |
| 2020-09-30 | 17.22% |
| 2020-06-30 | 12.86% |
| 2020-03-31 | 13.65% |
| 2019-12-31 | 14.82% |
| 2019-09-30 | 12.65% |
| 2019-06-30 | 12.95% |
| 2019-03-31 | 13.61% |
| 2018-12-31 | 14.05% |
| 2018-09-30 | 16.17% |
| 2018-06-30 | 15.47% |
| 2018-03-31 | 15.55% |
| 2017-12-31 | 15.63% |
| 2017-09-30 | 14.00% |
| 2017-06-30 | 14.92% |
| 2017-03-31 | 15.16% |
| 2016-12-31 | 13.87% |
| 2016-09-30 | 14.48% |
| 2016-06-30 | 18.18% |
| 2016-03-31 | 16.13% |
| 2015-12-31 | 15.07% |
| 2015-09-30 | 15.43% |
| 2015-06-30 | 11.50% |
| 2015-03-31 | 12.07% |
| 2014-12-31 | 12.88% |
| 2014-09-30 | 12.10% |
| 2014-06-30 | 19.11% |
| 2014-03-31 | 20.39% |
| 2013-12-31 | 21.43% |
| 2013-09-30 | 19.77% |
| 2013-06-30 | 13.25% |
| 2013-03-31 | 12.62% |
| 2012-12-31 | 13.30% |
| 2012-09-30 | 16.48% |
| 2012-06-30 | 17.44% |
| 2012-03-31 | 17.65% |
| 2011-12-31 | 18.01% |
| 2011-09-30 | 18.21% |
| 2011-06-30 | 19.47% |
| 2011-03-31 | 20.51% |
| 2010-12-31 | 17.87% |
| 2010-09-30 | 19.10% |
| 2010-06-30 | 18.62% |
| 2010-03-31 | 18.56% |
| 2009-12-31 | 18.28% |
| 2009-09-30 | 18.33% |
| 2009-06-30 | 17.00% |
| 2009-03-31 | 17.24% |
| 2008-12-31 | 16.13% |
| 2008-09-30 | 10.89% |
| 2008-06-30 | 10.73% |
| 2008-03-31 | 10.67% |
| 2007-12-31 | 10.23% |
| 2007-09-30 | 14.86% |
| 2007-06-30 | 17.47% |
| 2007-03-31 | 18.08% |
| 2006-12-31 | 19.42% |
| 2006-09-30 | 18.49% |
| 2006-06-30 | 18.68% |
| 2006-03-31 | 19.52% |
| 2005-12-31 | 19.77% |
| 2005-09-30 | 19.17% |
| 2005-06-30 | 19.31% |
| 2005-03-31 | 19.51% |
| 2004-12-31 | 21.81% |
| 2004-09-30 | 19.43% |
| 2004-06-30 | 19.32% |
| 2004-03-31 | 18.56% |
| 2003-12-31 | 18.24% |
| 2003-09-30 | 17.22% |
| 2003-06-30 | 15.89% |
